TEXT-EXTRACT 2 filename2.txt United States securities and exchange commission logo November 1, 2021 Haitham Khouri Chief Executive Officer and Director Perimeter Solutions, SA 12E rue Guillaume Kroll, L-1882 Luxembourg Grand Duchy of Luxembourg Re: Perimeter Solutions, SA Amendment No. 2 to Registration Statement on Form S-4 Filed October 25, 2021 File No. 333-259237 Dear Mr. Khouri: We have reviewed your amended registration statement and have the following comment. In our comment, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to this comment, we may have additional comments. Unless we note otherwise, our references to prior comments are to comments in our October 22, 2021 letter. Amendment No. 2 to Registration Statement on Form S-4, Filed October 25, 2021 The Business Combination Background of the Business Combination, page 78 1. We note your response to our prior comment number 7. Please confirm that all material analyses, including those of comparable companies or transactions, relied upon by the Board are disclosed in the registration statement. With respect to the projections, please also revise to state how the Board considered the effect of the passage of time over the five-year projection period and how this may affect the reliability of the projections, particularly in later years, or include a negative statement to that effect. Haitham Khouri FirstName LastNameHaitham Khouri Perimeter Solutions, SA Comapany 1, November NamePerimeter 2021 Solutions, SA November Page 2 1, 2021 Page 2 FirstName LastName You may contact Jenn Do at 202-551-3743 or Al Pavot at 202-551-3738 if you have questions regarding comments on the financial statements and related matters. Please contact Margaret Schwartz at 202-551-7153 or Laura Crotty at 202-551-7614 with any other questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Flora Perez, Esq.